Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Glutathione and glutathione S-transferases as early markers for ovarian carcinomas: case series (CROSBI ID 93327)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Šprem, Marina ; Babić, Damir ; Abramić, Marija ; Vrhovec, Ivan ; Škrk, Janez ; Miličić, Duško ; Ambriović Ristov, Andreja ; Kalafatić, Držislav ; Osmak, Maja Glutathione and glutathione S-transferases as early markers for ovarian carcinomas: case series // Croatian medical journal, 42 (2001), 6; 393-398-x

Podaci o odgovornosti

Šprem, Marina ; Babić, Damir ; Abramić, Marija ; Vrhovec, Ivan ; Škrk, Janez ; Miličić, Duško ; Ambriović Ristov, Andreja ; Kalafatić, Držislav ; Osmak, Maja

engleski

Glutathione and glutathione S-transferases as early markers for ovarian carcinomas: case series

Aim. To determine the activity of glutathione S-transferases (GST) and concentrations of glutathione (GSH) , urokinase plasminogen activator (uPA) and urokinase plasminogen activator inhibitor type 1 (PAI-1), and to evaluate their diagnostic and prognostic value and possible correlation with clinical and histopathological prognostic factors for ovarian carcinomas. Methods. The concentrations of GSH, uPA, PAI-1 and activity of GST were analyzed in 35 tissue samples taken from 10 normal ovaries, 10 benign, 10 primary malignant and 5 metastatic ovarian tumors. The GSH levels and GST activity were determined by spectrophotometric methods, and uPA and PA-I concentrations by ELISA commercial kits. Results. Glutathione concentrations were significantly higher in primary malignant (126.3+12.8 nmol/mg protein) and metastatic (160.5+24.3 nmol/mg protein) ovarian tumor specimens than in normal ovarian tissue (48.9+8.1 nmol/mg protein, p < 0.03 for both carcinoma groups) or benign ovarian tumor samples (35.2+5.0 nmol/mg protein, p=0.001). The GST activity was significantly higher in primary malignant (245.8+22.7 nmol/min/mg protein) and metastatic (303.7+48.8 nmol/min/mg protein) ovarian tumor tissues that in benign tumor specimens (105.9+16.2 nmol/min/mg protein, p < 0.004 for both carcinoma groups) or normal ovarian tissue samples (113.2+32.0 nmol/min/mg protein, p < 0.04 for both carcinoma groups). There were no statistical differences in uPA and PAI-1 concentrations between the normal, benign and malignant tumor samples. Concentrations of GSH, uPA and PAI-1, and activity of GST were independent from histolopathogical and clinical prognostic factors. Conclusions. Increased GSH concentration and GST activity found in primary malignant and metastatic ovarian tumor samples were independent of histopathological and clinical prognostic factors, suggesting that they could be early markers for ovarian carcinomas.

carcinoma; glutathione; glutathione S-transferases; ovarian neoplasms; urokinase type plasminogen activator; plasminogen activator inhibitor type 1

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

42 (6)

2001.

393-398-x

objavljeno

0353-9504

Povezanost rada

Kemija, Biologija

Indeksiranost